Switzerland is home to one of the world’s largest drug factories, a sprawling production site in the Rhone Valley town of Visp. Owned and operated by contract manufacturer Lonza, the Visp plant is one of several set to produce an experimental coronavirus vaccine being developed by Cambridge, Massachusetts-based Moderna.
Moderna’s vaccine is among the most advanced globally, having already progressed to mid-stage clinical testing. Lonza’s help will be critical in ensuring sufficient doses are made.
